Ovarian, Fallopian Tube and Primary Peritoneum tumors
This site uses cookies to offer you a better browsing experience. By continuing to access the web site, you agree that we will store personal data in a cookie as outlined in our Privacy Policy, which is also accessible from the sidebar.
Sign up to save, edit, and PDF your reports and access more resources.
How to use
Make your selections on the left
Your template will build on the right
Copy/Paste into your LIS
Uh Oh! It looks like you may have forgotten a required element in your template. Please review the
highlighted selections.
Some optional elements have been omitted. You can delete this from the synoptic if you don't want to include it.
Procedure (select all that apply)
Specimen Integrity
Integrity of Right Ovary
Integrity of Left Ovary
Integrity of Right Fallopian Tube
Integrity of Left Fallopian Tube
Tumor Site
A word about assigning primary site
From the CAP cancer protocol, note C
Ovarian Surface Involvement (required only if applicable)
Fallopian Tube Surface Involvement (required only if applicable)
Tumor Size (cm)
Histologic Type (select all that apply)
Histologic Grade
Required for serous, endometrioid, mucinous, and seromucinous carcinomas, immature teratomas, and Sertoli-Leydig cell tumors only
Note: Serous carcinomas are graded via a 2-tier system. Immature teratomas can be graded using a 2-tier or 3-tier system. Endometrioid and mucinous carcinomas are graded via a 3-tier system. Sertoli-Leydig cell tumors are graded via a modified 3-tier grading system with grade 2 tumors being termed “intermediate differentiated.” Clear cell carcinomas, borderline epithelial neoplasms, all other malignant sex-cord stromal and germ cell tumors are not graded.
WHO Grading System
Two-Tier Grading System (required for immature teratomas and serous carcinomas only)
Implants
Other Tissue/ Organ Involvement
Largest Extrapelvic Peritoneal Focus (required only if applicable)
Peritoneal / Ascitic Fluid Involvement
Chemotherapy Response Score (CRS)
A note about the CRS
From the CAP cancer protocol, note J
Required only for high-grade serous carcinomas. Treatment effect is based on assessment of the section of omentum
that shows the least response to chemotherapy.
